{"transactions":[{"id":3930384,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":166607,"kind":"organization","name":"Biotest AG","position":1,"cik":"0001709152","reported_name":"Biotest AG","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166608,"kind":"organization","name":"Biotest Pharmaceuticals Corp","position":2,"cik":"0001708960","reported_name":"Biotest Pharmaceuticals Corp","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Non-Voting Common Stock","published_at":"2018-05-16T21:00:28.000Z","date":"2018-05-14","kind":"sale","acquired":false,"shares":8591160,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Biotest Pharmaceuticals Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 14, 2018, pursuant to a Share Transfer, Amendment and Release Agreement, by and among, among other parties, the issuer, Biotest Pharmaceuticals Corporation (\"BPC\") and Biotest AG, BPC transferred to the issuer, for no cash consideration, 8,591,160 shares of the issuer's non-voting common stock previously issued to BPC in June 2017 and representing 100% of the issuer's then-issued and outstanding non-voting common stock."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares were owned directly by BPC, a ten percent owner of the issuer and a wholly owned subsidiary of Biotest AG, and indirectly by Biotest AG."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-18-000697","document":"e618019_4-biotest.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380518000697/e618019_4-biotest.xml","form_type":"4"}},{"id":4159946,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":166607,"kind":"organization","name":"Biotest AG","position":1,"cik":"0001709152","reported_name":"Biotest AG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166608,"kind":"organization","name":"Biotest Pharmaceuticals Corp","position":2,"cik":"0001708960","reported_name":"Biotest Pharmaceuticals Corp","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-17T02:32:21.000Z","date":"2017-11-09","kind":"purchase","acquired":true,"shares":5813954,"price":2.15,"value":12500001.1,"ownership":{"direct":false,"nature":"By Biotest Pharmaceuticals Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the issuer's public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Biotest Pharmaceuticals Corporation, a ten percent owner of the issuer and a wholly owned subsidiary of Biotest AG, and indirectly by Biotest AG. Biotest AG is a director and a ten percent owner of the issuer."}],"balance_after":10109534,"source":{"system":"sec-edgar","filing":"0001193805-17-003506","document":"e617500_4a-biotest.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380517003506/e617500_4a-biotest.xml","form_type":"4/A","original_submission_date":"2017-11-13"}},{"id":4165105,"issuer":{"id":4477,"kind":"organization","name":"ADMA BIOLOGICS, INC."},"owners":[{"id":166607,"kind":"organization","name":"Biotest AG","position":1,"cik":"0001709152","reported_name":"Biotest AG","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":166608,"kind":"organization","name":"Biotest Pharmaceuticals Corp","position":2,"cik":"0001708960","reported_name":"Biotest Pharmaceuticals Corp","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-13T18:54:54.000Z","date":"2017-11-09","kind":"purchase","acquired":true,"shares":5813954,"price":2.15,"value":12500001.1,"ownership":{"direct":false,"nature":"By Biotest Pharmaceuticals Corporation"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a purchase from the underwriters in the issuer's public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are owned directly by Biotest Pharmaceuticals Corporation, a ten percent owner of the issuer and a wholly owned subsidiary of Biotest AG, and indirectly by Biotest AG. Biotest AG is a director and a ten percent owner of the issuer."}],"balance_after":10109534,"source":{"system":"sec-edgar","filing":"0001193805-17-003457","document":"e617475_4-biotest.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1368514/000119380517003457/e617475_4-biotest.xml","form_type":"4"}}]}